Over the past decades, stem cells are being broadly used as regenerative medicine for repairing or replacing tissues that are damaged due to injury or diseases. With the advancement in stem cell therapy, scientists have now engineered stem cells that can effectively treat metastatic bone cancer without damaging surrounding normal tissues.
Image Credit: Kateryna Kon/Shutterstock.com
Stem cells are unspecialized cells with two distinct characteristics: unlimited self-renewal capacity; and the ability to differentiate into many types of tissue or organ-specific specialized cells.
So far, three types of stem cells have been identified. These include embryonic stem cells (derived from embryos); adult stem cells or somatic stem cells (derived from adult tissues); and induced pluripotent stem cells (genetic reprogramming of normal adult cells to induce embryonic stem cell-like properties).
Human stem cells are most commonly used in cell-based therapies, wherein stem cells are allowed to differentiate into specialized cells that can be used for tissue repair purposes. In patients with bone marrow injuries or damaged immune system, stem cells derived from bone marrow or blood can be transplanted to restore normal bone marrow functions.
This is called stem cell transplantation. This technique is widely used to treat bone cancer patients who suffer from chemotherapy-induced bone marrow damage or suppressed immunity.
In cancer patients, the functions of T cells, which play a key role in adaptive immunity, are altered in a way that facilitates cancer cells to escape T cell-mediated elimination. The generation of T cells from induced pluripotent stem cells that can specifically recognize and destroy cancer cells is another potential stem cell therapy to improve cancer-related prognosis.
Cancer stem cells play a crucial role in the onset and progression of cancer. The key steps in immune system-mediated cancer eradication include activation of cancer cell-specific T cells by antigen-presenting cells (dendritic cells, B cells, and macrophages); recognition of cancer stem cell-specific surface antigens by the activated T cells; and subsequent destruction of cancer stem cells.
In cancer vaccination, dendritic cells derived from stem cells can be loaded with cancer stem cell-specific surface antigens and infused into cancer patients to trigger an immune response that destroys cancer cells.
In cancer-related gene therapy, stem cells are used as a medium to carry and deliver therapeutic drugs or viral vectors specifically to tumor sites. The unique property of stem cells to migrate toward the site of injury is utilized in stem cell-based gene therapy. In particular, bone marrow mesenchymal stem cells are best suited for delivering therapeutics to tumor sites.
The cytokines secreted by tumors facilitate the migration process by stimulating mesenchymal stem cells to produce more chemokines, which are small cytokines responsible for directed cell migration.
Stem cells have been widely used for the treatment of bone cancers. For example, mesenchymal stem cell transplantation has become an attractive strategy to treat patients with bone disorders, including bone cancer.
Mechanistically, mesenchymal stem cells are induced to differentiate into osteoblasts, which in turn form the bone matrix on hydroxyapatite ceramics. Such implants are used to reconstruct the bone parts that are excised during the removal of bone tumors through limb salvage surgery.
Pathological destruction of the bone (osteolysis) is potent comorbidity of metastatic bone cancers. In the bone, metastatic cancer cells induce osteoclastogenesis, resulting in increased formation of osteoclasts. These cells are responsible for bone resorption characterized by increased bone tissue breakdown and release of bone minerals.
Therefore, stem cell-based targeted delivery of drugs that can inhibit osteoclastogenesis has become an important strategy to manage metastatic bone cancers.
Recently, a study has been carried out to develop mesenchymal stem cells that can concurrently express a combination of drugs for targeting both bone cancer and its microenvironment. Using the mRNA-based protein expression method, mesenchymal stem cells have been loaded with three distinct therapeutic drugs: one for specific homing of stem cells to the metastatic site; one for efficient destruction of cancer cells; and one which is a cytokine receptor for inhibiting osteoclastogenesis.
These engineered mesenchymal stem cells have been found to efficiently and specifically target the metastatic bone cancer probably due to increased interaction of P-selectin glycoprotein ligand-1/Sialyl-Lewis X with P-selectin, which is expressed on the blood vessels surrounding the tumor. Also, the stem cells have been found to effectively destroy the cancer cells without affecting bone integrity.
Image Credit: CI Photos/Shutterstock.com
The common therapeutic modules for bone cancer, such as surgery, chemotherapy, and radiotherapy, are mostly associated with adverse side-effects. Similarly, drugs that are used to prevent bone cancer-related comorbidities (osteolysis) do not generally have effective anti-tumor properties.
In cell-based targeted therapies, genetically modified cells are used to deliver only a single type of drug, which is not a very safe technique.
In contrast, mRNA-based engineering of mesenchymal stem cells comes with many advantages. For example, it is an easy and safe method as no genetic engineering is needed. This process allows the rapid and transient expression of multiple proteins at a time that can facilitate targeted cancer cell death with minimal side-effects.
Read more:
Engineering Stem Cells to Treat Bone Cancer - News-Medical.net
- Biology of stem cells: an overview - PMC - National Center for ... - March 26th, 2024
- Iron Limitation Preserves Youthfulness of Blood Stem Cells - Mirage News - March 13th, 2024
- Mini organs grown from stem cells of unborn babies for the first time in breakthrough - The Mirror - March 9th, 2024
- The Effect of Short-Term NAD3 Supplementation on Circulating Adult Stem Cells in Healthy Individuals Aged 40-70 ... - Cureus - March 7th, 2024
- University of Liverpool Spin-Out Emerges, Pioneering Novel Adult Stem Cell-Based Therapies - India Education Diary - March 7th, 2024
- Scientists have used cells from fluid drawn during pregnancy to grow mini lungs and other organs - Yahoo News Canada - March 6th, 2024
- Japan approves new stem cell-based Alzheimer's therapy By Proactive Investors - Investing.com Australia - January 20th, 2024
- Cyberstalking pits Harvard professor against PubPeer Retraction ... - Retraction Watch - December 5th, 2023
- 10 functional health predictions for 2024, according to a doctor and ... - 1330 WFIN - December 5th, 2023
- See the Brain Like Never Before in This Gorgeous Art - Scientific American - December 5th, 2023
- Geron Announces Publication in The Lancet of Results from the ... - BioSpace - December 5th, 2023
- Stem cell injections could be the key to curing MS - Freethink - December 3rd, 2023
- Jaypirca (pirtobrutinib) Now Approved by U.S. FDA for the ... - Investors | Eli Lilly and Company - December 3rd, 2023
- Comparative Efficacy and Safety of Four JAK Inhibitors for ... - HealthDay - December 3rd, 2023
- City lights up for Francis on Anthony Nolan's birthday - Liverpool Express - December 3rd, 2023
- NOT-AR-23-022: Request for Information on Themes for the NIAMS ... - National Institutes of Health (.gov) - December 3rd, 2023
- December 2023: Intramural Papers of the Month - Environmental Factor Newsletter - December 1st, 2023
- CNA Explains: What is cord blood banking and why do parents do it? - CNA - December 1st, 2023
- Regulation of myogenesis and adipogenesis by the electromagnetic ... - Nature.com - December 1st, 2023
- The effects of vitamin K on bone health - News-Medical.Net - December 1st, 2023
- Dr Hurwitz on Ongoing Investigations of the Use of CAR T-Cell ... - OncLive - December 1st, 2023
- Mitophagy in human health, ageing and disease - Nature.com - December 1st, 2023
- Adult Stem Cells - Stem Cells and the Future of Regenerative Medicine ... - November 29th, 2023
- Navigating The Regulatory Landscape Of Longevity Health Products ... - Mondaq News Alerts - November 29th, 2023
- MS breakthrough could lead to treatments that halt disease's ... - inews - November 29th, 2023
- Reprogramming tissue mechanically to promote wound healing - Phys.org - November 29th, 2023
- Latest Advances in Arthritis Diagnosis and Treatment at American ... - HealthDay - November 29th, 2023
- Sex-associated differences in frequencies and prognostic impact of ... - Nature.com - November 29th, 2023
- Hematologists Dive into the Current Treatment Landscape - OncLive - November 29th, 2023
- Team discovers protein crucial for B cell differentiation and antibodies - Phys.org - November 29th, 2023
- Science Talk - I survived cancer as a child and now I'm working to ... - The Institute of Cancer Research - November 29th, 2023
- First Edition: Nov. 29, 2023 - KFF Health News - November 29th, 2023
- Symptoms: Unilateral Hearing Loss and Tinnitus : The Hearing Journal - LWW Journals - November 29th, 2023
- Mitigation of sepsis-induced acute lung injury by BMSCs | IJN - Dove Medical Press - November 29th, 2023
- A Case of a Constricted Vessel: The Impact of Acute Myeloid ... - Cureus - November 29th, 2023
- Mum brushed off fatigue after having baby but fall sparked deadly diagnosis - The Mirror - November 29th, 2023
- How heritable is the epigenome? - Drug Discovery News - November 29th, 2023
- The Blueprint of Regeneration: Scientists Discover How to Turn Stem Cells Fate - Revyuh - November 27th, 2023
- BrainStorm Cell Therapeutics Announces In-Person Meeting with ... - Marketscreener.com - November 27th, 2023
- Stem Cell Therapy Developed in Korea Begins Treatment for ... - PharmiWeb.com - November 25th, 2023
- COVID-19 Pandemic's Adverse Effect on Bone Health in Young ... - HealthDay - November 25th, 2023
- Sickle cell breakthrough - The Indian Express - November 25th, 2023
- Wall thickness analysis method for judging the degree of lower ... - Nature.com - November 25th, 2023
- Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference - Yahoo Finance - November 23rd, 2023
- Disease Transmission and Diagnosis of Zika Virus - Cureus - November 23rd, 2023
- Gene-editing therapy for sickle cell earns conditional approval in UK - Sickle Cell Disease News - November 23rd, 2023
- Stem Cell Therapy Developed in Korea Begins Treatment for ... - Newswire - November 21st, 2023
- Efficacy of ADSC-CM in Patients with Telogen Effluvium | SCCAA - Dove Medical Press - November 21st, 2023
- BrainStorm Cell Therapeutics Announces In-Person Meeting with ... - PR Newswire - November 21st, 2023
- The Impact of CAR T Cell Therapy on Managing R/R LBCL - OncLive - November 21st, 2023
- Mansour bin Zayed witnesses inauguration of ADSCC Bone Marrow Transplant & Cellular Therapy Congress 2023 - ZAWYA - November 21st, 2023
- Listeria: Who is most susceptible? What are the Symptoms? What ... - Food Poison Journal - November 21st, 2023
- Scope Of Issued Patents May Be Limited By Prosecution Estoppel ... - Mondaq News Alerts - November 21st, 2023
- Qrons Announces the Addition of Professor Shiri Navon-Venezia to ... - StreetInsider.com - November 21st, 2023
- Financially strapped Athersys raises $10.4M - cleveland.com - November 19th, 2023
- From the India Today archives (2010) | How stem cells can save your life - India Today - November 19th, 2023
- Inactivation of the tumor suppressor gene Apc synergizes with H ... - Science - November 19th, 2023
- The Origins of Multiple Myeloma and Why it Matters - HealthTree For AML - Acute Myeloid Leukemia - November 19th, 2023
- Treatment Considerations With TROP2-Targeted Therapy - OncLive - November 19th, 2023
- Athersys narrows loss, raises $10.4 million during third quarter to ... - The Business Journals - November 17th, 2023
- Who was Dolly the Sheep and what happened to her? The story of ... - BBC Countryfile Magazine - November 17th, 2023
- UK first to approve CRISPR treatment for diseases: what you need to ... - Nature.com - November 17th, 2023
- 1st sickle cell patient to be given therapy restoring fetal hemoglobin - Sickle Cell Disease News - November 15th, 2023
- Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates - Century - Benzinga - November 13th, 2023
- Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer - Yahoo Finance - November 11th, 2023
- Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in... - November 11th, 2023
- AAO 2023: Paul Runge and his ROP treatments in the Ukraine - Modern Retina - November 11th, 2023
- The Evolutionary Reasons We Are Drawn To Horror Movies and ... - Slashdot - November 11th, 2023
- Century Therapeutics Reports Third Quarter 2023 Financial Results ... - GlobeNewswire - November 11th, 2023
- Century Therapeutics Reports Third Quarter 2023 Financial Results ... - StreetInsider.com - November 9th, 2023
- NYU Langone Health Performs World's First Whole-Eye & Partial ... - NYU Langone Health - November 9th, 2023
- BrainStorm to Announce Third Quarter 2023 Financial Results and ... - BioSpace - November 9th, 2023
- Can we cut cost and pain of IVF? Start-up CEO tries out own ... - Genetic Literacy Project - November 9th, 2023
- Jasper Therapeutics Reports Third Quarter 2023 Financial Results ... - BioSpace - November 9th, 2023
- Impaired neural stress resistance and loss of REST in bipolar ... - Nature.com - November 9th, 2023
- Functional genomics and systems biology in human neuroscience - Nature.com - November 9th, 2023
- Trial launched to test CAR T-cell therapy in dogs diagnosed with ... - EurekAlert - November 9th, 2023
- The-Gut's-Lasting-Impact-on-Severe-COVID-19-Immune-Response - Infectious Disease Special Edition - November 9th, 2023
- Emerging Cure for Sickle Cell on its Way to FDA Approval, Carries ... - Dallasweekly - November 7th, 2023
- The science works, but will we pay for it? - Irish Medical Times - November 7th, 2023
Recent Comments